FMR CORP 13D/13G Filings for G1 Therapeutics, Inc. (GTHX)

FMR CORP 13D and 13G filings for G1 Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-02-08
10:23 am
Sale		 2021-02-05 13G G1 Therapeutics, Inc.
GTHX		 FMR CORP 923,939
2.428%		 -1,620,598decrease
(-63.69%)		 Filing
2020-11-10
10:27 am
Sale		 2020-11-09 13G G1 Therapeutics, Inc.
GTHX		 FMR CORP 2,544,537
6.693%		 -3,092,689decrease
(-54.86%)		 Filing